- From: Eric Neumann <eneumann@teranode.com>
- Date: Tue, 15 May 2007 09:01:53 -0400
- To: public-hcls-dse@w3.org
- Message-ID: <5FB2023D-8A8E-4B50-B371-3D15761D1F29@teranode.com>
I thought it would be useful to outline the items we are considering as part of DSE, namely... 1) Electronic Clinical Data Capture, addressing elaborate and adaptive study designs 2) Biomarker and genetic testing and diagnostics 3) Enhanced Organization of data to support deeper mining and re-use of data, i.e, mechanisms of action, toxicity analyses In addition, looking at what is on the CTO wiki, I felt it might be useful to provide an outline for the essential components of a clinical trial.. please adjust as you see fit... Clinical Trial Components Study Goals NCE Therapeutic Value Clinical Stage Safety POC/Efficacy Study Design Arms Dosing Size Group Pre-selection Treatment Termination plan Adaptive Model (if used) Recruitment Plan Study Recruitment Clinical Centers Subject classification and segmentation Criteria Release Forms Study Execution Visits Drug and Vehicle treatment Observations / Tests i. Vital Signs ii. Assays iii. Biomarker sampling Treatment Termination Follow up visits Database Locking SOP Compliance QA Admin decision Analysis Statistical analyses Expert inspection Interpretation Decision Point Report generation Submission Plan Document compilation Inspection Reviews Decision Point Final review Final Decision Point Submission See you soon! Eric
Received on Tuesday, 15 May 2007 13:02:09 UTC